Vassell R - Search Results

1

Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge.

Glenn GM, Scharton-Kersten T, Vassell R, Mallett CP, Hale TL, Alving CR. Glenn GM, et al. Among authors: vassell r. J Immunol. 1998 Oct 1;161(7):3211-4. J Immunol. 1998. PMID: 9759833

2

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants.

Glenn GM, Scharton-Kersten T, Vassell R, Matyas GR, Alving CR. Glenn GM, et al. Among authors: vassell r. Infect Immun. 1999 Mar;67(3):1100-6. doi: 10.1128/IAI.67.3.1100-1106.1999. Infect Immun. 1999. PMID: 10024549 Free PMC article.

3

Principles of transcutaneous immunization using cholera toxin as an adjuvant.

Scharton-Kersten T, Glenn GM, Vassell R, Yu J, Walwender D, Alving CR. Scharton-Kersten T, et al. Among authors: vassell r. Vaccine. 1999 Oct 1;17 Suppl 2:S37-43. doi: 10.1016/s0264-410x(99)00233-9. Vaccine. 1999. PMID: 10506407

4

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants.

Scharton-Kersten T, Yu Jm, Vassell R, O'Hagan D, Alving CR, Glenn GM. Scharton-Kersten T, et al. Among authors: vassell r. Infect Immun. 2000 Sep;68(9):5306-13. doi: 10.1128/IAI.68.9.5306-5313.2000. Infect Immun. 2000. PMID: 10948159 Free PMC article.

5

Cell-mediated immunity in owl monkeys following inoculation with hepatitis A virus.

Asher LV, Vassell RA, Binn LN, Polotsky YE. Asher LV, et al. Among authors: vassell ra. Adv Exp Med Biol. 1995;371B:1591-3. Adv Exp Med Biol. 1995. PMID: 7502862 No abstract available.

6

Pathogenesis of hepatitis A in orally inoculated owl monkeys (Aotus trivirgatus).

Asher LV, Binn LN, Mensing TL, Marchwicki RH, Vassell RA, Young GD. Asher LV, et al. Among authors: vassell ra. J Med Virol. 1995 Nov;47(3):260-8. doi: 10.1002/jmv.1890470312. J Med Virol. 1995. PMID: 8551278

7

Immunohistochemical detection of cytokines in tissues of Aotus monkeys infected with hepatitis A virus.

Polotsky YE, Vassell RA, Binn LN, Asher LV. Polotsky YE, et al. Among authors: vassell ra. Ann N Y Acad Sci. 1994 Aug 15;730:318-21. doi: 10.1111/j.1749-6632.1994.tb44279.x. Ann N Y Acad Sci. 1994. PMID: 8080199

8

Recombinant A27 protein synergizes with modified vaccinia Ankara in conferring protection against a lethal vaccinia virus challenge.

He Y, Meseda CA, Vassell RA, Merchlinsky M, Weir JP, Weiss CD. He Y, et al. Vaccine. 2010 Jan 8;28(3):699-706. doi: 10.1016/j.vaccine.2009.10.078. Epub 2009 Nov 1. Vaccine. 2010. PMID: 19887133

9

Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity.

He Y, Manischewitz J, Meseda CA, Merchlinsky M, Vassell RA, Sirota L, Berkower I, Golding H, Weiss CD. He Y, et al. J Infect Dis. 2007 Oct 1;196(7):1026-32. doi: 10.1086/520936. Epub 2007 Aug 20. J Infect Dis. 2007. PMID: 17763325

10

Characterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization assays.

Wang W, Xie H, Ye Z, Vassell R, Weiss CD. Wang W, et al. Among authors: vassell r. J Virol Methods. 2010 May;165(2):305-10. doi: 10.1016/j.jviromet.2010.02.009. Epub 2010 Feb 11. J Virol Methods. 2010. PMID: 20153374

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters